<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Comparative analysis of using <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers in 159 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was made </plain></SENT>
<SENT sid="1" pm="."><plain>Carcinoembryonal antigen, skin reaction of hypersensitivity of slow type with autologous modified lymphocytes and a diagnostic test of <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> were used as oncomarkers </plain></SENT>
<SENT sid="2" pm="."><plain>Each of three markers may be used for preoperative staging of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, postoperative monitoring of patients and determination of the disease prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>An individual approach of assessment of the oncomarker level at different stages of examining the patient is recommended </plain></SENT>
</text></document>